[ad_1]
The European Commission has already signed contracts for the supply of COVID-19 with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica and has successfully completed preparatory negotiations with CureVac and Moderna.
“A safe and effective vaccine is the only long-term strategy to overcome a pandemic. Today’s agreement builds on the first promising results from clinical trials and further confirms our commitment to expanding the capabilities of the European healthcare system,” he said EU Health Commissioner Stella Kyriakidis at a short press conference in Brussels.
“With this fourth agreement, we are consolidating a highly reliable portfolio of candidate vaccines, most of which are in the advanced testing phase,” the EC report said, quoting its president, Ursula von der Leyen.
“Reuters” / “Scanpix” nuotr./Ursula von der Leyen
The European Medicines Agency (EMA) announced earlier this week that it did not yet have clinical trial data from Pfizer to approve the vaccine, which manufacturers say is 90 percent effective.
Earlier, officials said Brussels would take until next year to authorize distribution of the vaccines, although it had sped up the approval process.
[ad_2]
